Korro Bio, Inc. SEC filings KRRO

Korro Bio, Inc. has 830 filings in SEC EDGAR's recent list, going back to Apr 14, 2017. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, results of operations). The company's fiscal year ends on December 31.

Korro Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Agreement ended, Results of operations
Nov 5, 2026 Nov 3, 2026
8-K Current report
Other events
Oct 22, 2026 Oct 22, 2026
8-K Current report
Other events
Oct 5, 2026 Oct 5, 2026
8-K Current report
Other events
Aug 19, 2026 Aug 19, 2026
8-K Current report
Material agreement, Results of operations, Unregistered share sale
Aug 6, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
8-K Current report
Other events
May 19, 2026 May 19, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Other events
Jan 27, 2026 Jan 27, 2026
8-K Current report
Other events
Jan 15, 2026 Jan 15, 2026
8-K Current report
Officer or director change
Dec 18, 2025 Dec 15, 2025
8-K Current report
Material agreement, Results of operations, Exit or restructuring costs, Officer or director change
Nov 12, 2025 Nov 7, 2025
8-K Current report
Officer or director change
Oct 8, 2025 Oct 7, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K/A Amended current report
Shareholder vote results
Jun 18, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 11, 2025
8-K Current report
Results of operations, Exit or restructuring costs
May 7, 2025 May 7, 2025
8-K Current report
Officer or director change
Mar 27, 2025 Mar 27, 2025
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
8-K Current report
Officer or director change
Feb 11, 2025 Feb 11, 2025
8-K Current report
Other events
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Nov 21, 2024 Nov 21, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Other events
Nov 4, 2024 Nov 4, 2024
8-K Current report
Material agreement
Sep 16, 2024 Sep 13, 2024
8-K Current report
Officer or director change
Aug 28, 2024 Aug 26, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Officer or director change
Jun 21, 2024 Jun 17, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 12, 2024 Jun 11, 2024
8-K Current report
Other events
May 14, 2024 May 13, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Other events
Apr 22, 2024 Apr 22, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 18, 2024 Apr 17, 2024
8-K Current report
Results of operations
Mar 26, 2024 Mar 26, 2024
8-K Current report
Other events
Jan 9, 2024 Jan 9, 2024
8-K Current report
Officer or director change
Nov 29, 2023 Nov 27, 2023
8-K Current report
Officer or director change
Nov 14, 2023 Nov 8, 2023
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
Nov 6, 2023 Nov 3, 2023
8-K Current report
Agreement ended, Other events
Sep 27, 2023 Sep 26, 2023
8-K Current report
Agreement ended
Aug 15, 2023 Aug 11, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change
Jul 31, 2023 Jul 28, 2023
8-K Current report
Material agreement, Change in control, Officer or director change
Jul 14, 2023 Jul 14, 2023
8-K Current report
Regulation FD disclosure
Jul 14, 2023 Jul 14, 2023
8-K Current report
Exit or restructuring costs, Officer or director change
Jun 6, 2023 May 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
8-K Current report
Officer or director change
May 10, 2023 May 5, 2023
8-K Current report
Listing notice, Officer or director change
Mar 29, 2023 Mar 23, 2023
8-K Current report
Results of operations
Mar 10, 2023 Mar 10, 2023
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Feb 13, 2023 Feb 13, 2023
8-K Current report
Regulation FD disclosure
Dec 13, 2022 Dec 13, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Regulation FD disclosure
Sep 12, 2022 Sep 12, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Material agreement
Jul 12, 2022 Jul 8, 2022
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 21, 2022
8-K Current report
Results of operations
May 4, 2022 May 4, 2022
8-K Current report
Officer or director change
Apr 15, 2022 Apr 11, 2022
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Apr 8, 2022 Apr 5, 2022
8-K Current report
Officer or director change
Mar 31, 2022 Mar 25, 2022
8-K Current report
Regulation FD disclosure, Other events
Mar 18, 2022 Mar 18, 2022
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
8-K Current report
Regulation FD disclosure
Jan 13, 2022 Jan 13, 2022
8-K Current report
Material agreement
Dec 10, 2021 Dec 10, 2021
8-K Current report
Regulation FD disclosure, Other events
Dec 9, 2021 Dec 9, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Nov 9, 2021 Nov 9, 2021
8-K Current report
Other events
Oct 21, 2021 Oct 21, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 22, 2021 Sep 22, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2021 Aug 12, 2021
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 17, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
8-K Current report
Results of operations
Mar 29, 2021 Mar 29, 2021
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 23, 2021 Mar 23, 2021
8-K Current report
Regulation FD disclosure
Feb 22, 2021 Feb 22, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Agreement ended
Dec 16, 2020 Dec 11, 2020
8-K Current report
Material agreement, New debt
Dec 15, 2020 Dec 11, 2020
8-K Current report
Officer or director change
Dec 1, 2020 Dec 1, 2020
8-K Current report
Results of operations
Nov 16, 2020 Nov 16, 2020
8-K Current report
Regulation FD disclosure, Other events
Oct 29, 2020 Oct 29, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 25, 2020 Sep 23, 2020
8-K Current report
Results of operations
Aug 12, 2020 Aug 12, 2020
8-K Current report
Material agreement, Unregistered share sale
Jul 21, 2020 Jul 17, 2020
8-K Current report
Shareholder vote results
Jun 12, 2020 Jun 11, 2020
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2020 May 14, 2020
8-K Current report
Regulation FD disclosure
Apr 30, 2020 Apr 30, 2020
8-K Current report
Results of operations
Mar 26, 2020 Mar 26, 2020
8-K Current report
Material agreement
Jan 13, 2020 Jan 13, 2020
8-K Current report
Results of operations
Nov 18, 2019 Nov 18, 2019
8-K Current report
Material agreement
Nov 14, 2019 Nov 14, 2019
8-K Current report
Bylaw or fiscal year change
Oct 7, 2019 Oct 7, 2019

Showing 95 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KRRO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1703647
Former names
Frequency Therapeutics, Inc. (until Nov 6, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.